Bayer Co.Lab Connect
Your Gateway to the Global Biotech Ecosystem
Bayer Co.Lab is a global network of life science incubators connecting early-stage entrepreneurs with world-class expertise, resources, and partners across key innovation hubs— Berlin, Boston, Shanghai/Beijing, and Kobe/Tokyo. Now, we're bringing this global platform to Switzerland.
Bayer Co.Lab Basel is designed to help Swiss startups bridge the gap between exceptional local science and global opportunity. Through this program, selected startups will gain direct access to Bayer's global network of R&D experts, investors, and ecosystem partners — accelerating their path to international growth.
Important: This program is specifically designed to help startups grow by providing valuable resources and connections, all while they continue to operate from Switzerland.
In partnership with
What We're Looking For
We're seeking innovative startups in the following areas;
Therapeutics
Women’s Health, Oncology, Nephrology, Cardiovascular Diseases, and Immunology — across modalities
Cell and Gene Therapy (CGT)
Women’s Health, Cardio, Renal, Ophthalmology, CNS, and Rare Diseases
Platform Technologies
Tissue-specific delivery, RNA-based therapies, cell-penetrating peptides, new covalent chemistries, new pocket discovery, AI for de novo design and toxicity prediction
Basel Co.Lab
Qualifications & Benefits
Who Can Apply
Location
Startups that have or plan to have operations in Switzerland
Stage
Pre-seed, Seed, Series A, or Series B
Requirements
- Proprietary assets and/or technologies in the above areas of interest
- Self-funded
- Availability to participate in the full selection process
What You'll Receive
Co.Lab Connect Winner
(1 company)
Non-Dilutive Capital
- 50,000 CHF grant to support operations at a Superlab Suisse location with ‘no strings attached’
Deep Integration with Bayer Co.Lab
- Complimentary ‘Bayer Co.Lab’ membership for one year, and
- Complimentary global hot-desk access for one year
Bayer Mentorship & Global Network
- Direct access to Bayer experts via the AdVise mentorship program to understand Bayer’s view on your technology and explore collaboration paths
- Opportunities to present at selected Bayer Co.Lab and partner events
Visibility Across Bayer Co.Lab Community
- After the one-year program, winners continue as Co.Lab portfolio alumni — maintaining long-term access to Co.Lab's global network
Financial Support
- Promotion to Bayer Co.Lab partners (Superlab Suisse, Qiming, Goodwin)
- Curated warm introductions to investors and ecosystem players
Program Timeline
JUNE 10th 2026
Application deadline
Mid-july 2026
Semi-finalists announced
early October , 2026
In-Person Event at Superlab Suisse & Winner Announcement
Time left to apply
How to Apply
Please submit the following documents by June 10, 2026. Provide non-confidential information only.
Required Documents
Non-confidential slide deck of your assets and/or technologies
Business profile including:
- Name and contact details of applicant (company name and registered address)
- Asset/Platform description
- Target therapeutic area/Indication
Submission:
To submit your application, please complete the form below after verifying that you are applying to the correct Co.Lab Connect program (Basel or Seoul).
By registering, you acknowledge that your information may be shared with the event’s partners for purposes related to this event.
Apply Now to Bayer Co.Lab Connect Basel